Clinical Trials Directory

Trials / Completed

CompletedNCT01101685

Neural Responses and Dysphoria: Modulation by a Pharmacological Probe

Blood Oxygen Level Dependent (BOLD) Responses During Emotional and Cognitive Processing in Dysphoric and Non-dysphoric Participants and Their Modulation by a Pharmacological Probe of Serotonin Function

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study aims to improve understanding of how people with low mood and negative feelings (known as dysphoric) may be different from people with normal mood and feelings (nondysphoric) when responding to a variety of social and emotional information. The study will look at the patterns of activity in peoples' brains in situations (presented as a battery of tests) after treatment with a medicine (escitalopram) or a placebo. The results from this study will help to gather information about the effectiveness of the various tests being used in this study in detecting any changes due to treatment with an antidepressant. Half the volunteers taking part in this study will be dysphoric (mildly depressed) whilst the other half of volunteers will be healthy volunteers. It is hoped that the results of this study will provide guidance for assessing effectiveness of new medicines and potentially help with the treatment of depression.

Conditions

Interventions

TypeNameDescription
DRUGEscitalopram7 days dosing of 10mg per day
DRUGPlacebo7 days dosing at 10mg daily

Timeline

Start date
2010-02-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2010-04-12
Last updated
2011-06-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01101685. Inclusion in this directory is not an endorsement.